An expert from AstraZeneca will discuss the use of antibody drugs, how they function and the different techniques used to characterize them in the drug development process.
This is the fourth of five events in the Bruker COVID-19 Webinar Series.
During this webinar, Dr. Maurizio Muroni from Astra Zeneca, will deliver an introduction on what antibodies are, their structure and an overview of some of the analytical techniques used for their structural characterization.
Presenters
Scientist
AstraZeneca
Production Partner
Bruker BioSpin
Additional Content From Bruker BioSpin
Stimulating and Recording Neuronal Activity During Traditional fMRI, and the Benefits When Doing This at “Zero” Echo Time
Experts discuss electrical and optical-based techniques capable of stimulating and recording neuronal activity during fMRI, share examples using these tools to study neurovascular coupling, and introduce a method to acquire fMRI data at zero echo time and discuss the advantages over traditional fMRI technique.
In-Situ Electrochemical EPR for Real-Time Measurements of Radical Ions
Dr. Raanan Carmieli discusses the use of electron paramagnetic resonance (EPR) as a powerful technique for the study of transition metals, organic radical ions and transient radical-pairs in photoexcited systems.
Introduction to CEST for MRI Assessment of Brain Ischemia and Cancer Lesions
Dr. Marty Pagel introduces the CEST MRI technique, demonstrates a basic experiment, and explains why measuring protein, acid, and metabolite content can be so beneficial in applications of brain ischemia and cancer.
Related Content
A Comprehensive How-To Demonstration of Higher Throughput Excitation-Contraction Coupling Investigations
Join Michiel Helmes and Diederik Kuster as they demonstrate best practices and new techniques in high-content, higher throughput investigations of excitation-contraction coupling in isolated cardiomyocytes.
Anti-Obesity Pharmacotherapy: Where are we now? Where are we going?
OBESITY SERIES 2020: Dr. Ania Jastreboff discusses the current use of anti-obesity pharmacotherapy, mechanisms involved, and agents in various stages of development with considerations for next steps.
COVID-19 – What’s NMR got to do with it?
Dr. Sharman explains the impact of using NMR for the quality control and release of drug molecules currently in shortage due to the Coronavirus pandemic.